Journal of labelled compounds and radiopharmaceuticals p. 229 - 235 (2006)
Update date:2022-08-03
Topics:
Oba, Makoto
Ohkuma, Kosuke
Hitokawa, Hiroshi
Shirai, Ayumi
Nishiyama, Kozaburo
Novel 3,4-didehydropyroglutamate derivatives, the key intermediates in this synthesis, were obtained from a protected pyroglutamate by the well-known selenenylation-oxidative deselenenylation method and were catalytically deuterated using a slow-addition technique. The obtained deuterated pyroglutamates were converted to [3,4-2H2]glutamic acid, [3,4,5-2H3]proline, and [3,4,5,5,5-2H 5]leucine via an appropriate functional group interconversions followed by the standard deprotection procedure. Copyright
View MoreJinan Jianfeng Chemical Co., Ltd
Contact:0086-531-88110457
Address:sales01(-a-t-)pharmachemm{dot}c+o+m
TIANJIN DONGRUXIANG MINERALS MARKETING CO.,LTD(expird)
Contact:22-58516360
Address:tianjin
Contact:+86-18653358619
Address:zibo
Hangzhou Haiqiang Chemical Co.,Ltd.
Contact:+86-571-86960370
Address:Add: 5/F, Around Town North Road,No. 10, Hangzhou, Zhejiang,China
SuZhou Ascepion Pharmaceuticals, Inc.(expird)
Contact:0512-86881668
Address:Building C,68Xingqing Road,Suzhou,China.
Doi:10.1002/anie.200600666
(2006)Doi:10.1016/j.electacta.2006.05.023
(2006)Doi:10.1007/BF00579470
(1984)Doi:10.1016/S0040-4039(01)80212-4
(1984)Doi:10.1021/ja064737l
(2006)Doi:10.1016/j.bmc.2007.08.046
(2007)